InsidersTradesSigma
셀레믹스: directors' dealings · South Korea · DART (FSS)
DART:company-6ebfc0KR·DART (FSS)Mcap 156.2Bn€Healthcare
Explore the full directors' dealings record of 셀레믹스, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Healthcare sector, 셀레믹스 has recorded 4 public disclosures. Market capitalisation: €156.2bn. The latest transaction was reported on 7 May 2026 — Purchase. Among the most active insiders: 수피쇼 신기술투자조합1호. The full history is free.
4
Insider Decl.
0
Thresholds
€9m
2 ops.
Buy Volume
€1m
1 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
15940.00 €
Analyst consensus
Income statement
Revenue5.77 Bn€
Gross profit2.87 Bn€50% margin
Net income−4.04 Bn€-70.0% margin
Valuation
Beta-0.36
Balance sheet & cash
Market cap156.16 Bn€
Total debt376.7 M€
Free Cash Flow−3.76 Bn€
Debt / Equity2%
Profitability & ownership
ROE-16.1%
ROA-7.7%
% insiders15.7%
% institutions0.0%
Last declaration on 7 May 2026
Declarations4 total
Executives●Purchase4DART
€9m1,021,143 shares
KRX
DART:20260507000371·
Ideal exit: 1 Feb 2027 (T+270)
Executives●Other0DART
DART:20260316001499·details not loaded
4 of 4 declarations